A systematic approach to adnexal masses discovered on ultrasound: the ADNEx MR scoring system

  • Elizabeth A. Sadowski
  • Jessica B. Robbins
  • Andrea G. Rockall
  • Isabelle Thomassin-Naggara
Pictorial essay

Abstract

Adnexal lesions are a common occurrence in radiology practice and imaging plays a crucial role in triaging women appropriately. Current trends toward early detection and characterization have increased the need for accurate imaging assessment of adnexal lesions prior to treatment. Ultrasound is the first-line imaging modality for assessing adnexal lesions; however, approximately 20% of lesions are incompletely characterized after ultrasound evaluation. Secondary assessment with MR imaging using the ADNEx MR Scoring System has been demonstrated as highly accurate in the characterization of adnexal lesions and in excluding ovarian cancer. This review will address the role of MR imaging in further assessment of adnexal lesions discovered on US, and the utility of the ADNEx MR Scoring System.

Keywords

Adnexal lesion Ovarian lesion Ovarian cancer Adnexal cyst Ovarian cyst MRI 

Notes

Financial disclosure

None.

References

  1. 1.
    Fishman DA, Cohen L, Blank SV, et al. (2005) The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol 192:1214–1221 (discussion 1221-1212)CrossRefPubMedGoogle Scholar
  2. 2.
    Sharma A, Apostolidou S, Burnell M, et al. (2012) Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). Ultrasound Obstet Gynecol 40:338–344CrossRefPubMedGoogle Scholar
  3. 3.
    Stukan M, Dudziak M, Ratajczak K, Grabowski JP (2015) Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses. J Ultrasound Med 34:207–217CrossRefPubMedGoogle Scholar
  4. 4.
    Timmerman D, Ameye L, Fischerova D, et al. (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Cadron I, Leunen K, Van Gorp T, et al. (2007) Management of borderline ovarian neoplasms. J Clin Oncol 25:2928–2937CrossRefPubMedGoogle Scholar
  6. 6.
    Darai E, Fauvet R, Uzan C, et al. (2013) Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update 19:151–166CrossRefPubMedGoogle Scholar
  7. 7.
    Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A (2006) Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 100:185–191CrossRefPubMedGoogle Scholar
  8. 8.
    Medeiros LR, Freitas LB, Rosa DD, et al. (2011) Accuracy of magnetic resonance imaging in ovarian tumor: a systematic quantitative review. Am J Obstet Gynecol 204:67.e61-10CrossRefGoogle Scholar
  9. 9.
    Mohaghegh P, Rockall AG (2012) Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. Radiographics 32:1751–1773CrossRefPubMedGoogle Scholar
  10. 10.
    Sayasneh A, Ekechi C, Ferrara L, et al. (2015) The characteristic ultrasound features of specific types of ovarian pathology (review). Int J Oncol 46:445–458CrossRefPubMedGoogle Scholar
  11. 11.
    Spencer JA, Ghattamaneni S (2010) MR imaging of the sonographically indeterminate adnexal mass. Radiology 256:677–694CrossRefPubMedGoogle Scholar
  12. 12.
    Braicu EI, Sehouli J, Richter R, et al. (2012) Primary versus secondary cytoreduction for epithelial ovarian cancer: a paired analysis of tumour pattern and surgical outcome. Eur J Cancer 48:687–694CrossRefPubMedGoogle Scholar
  13. 13.
    Bristow RE, Chang J, Ziogas A, Anton-Culver H (2013) Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol 121:1226–1234CrossRefPubMedGoogle Scholar
  14. 14.
    Earle CC, Schrag D, Neville BA, et al. (2006) Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 98:172–180CrossRefPubMedGoogle Scholar
  15. 15.
    Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R (2011) Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev 8:Cd007565Google Scholar
  16. 16.
    Engelen MJ, Kos HE, Willemse PH, et al. (2006) Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 106:589–598CrossRefPubMedGoogle Scholar
  17. 17.
    Woo YL, Kyrgiou M, Bryant A, Everett T, Dickinson HO (2012) Centralisation of services for gynaecological cancers: a Cochrane systematic review. Gynecol Oncol 126:286–290CrossRefPubMedGoogle Scholar
  18. 18.
    Vergote I, De Brabanter J, Fyles A, et al. (2001) Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176–182CrossRefPubMedGoogle Scholar
  19. 19.
    Brown DL, Doubilet PM, Miller FH, et al. (1998) Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 208:103–110CrossRefPubMedGoogle Scholar
  20. 20.
    Buys SS, Partridge E, Greene MH, et al. (2005) Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 193:1630–1639CrossRefPubMedGoogle Scholar
  21. 21.
    Castillo G, Alcazar JL, Jurado M (2004) Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol 92:965–969CrossRefPubMedGoogle Scholar
  22. 22.
    Ekerhovd E, Wienerroith H, Staudach A, Granberg S (2001) Preoperative assessment of unilocular adnexal cysts by transvaginal ultrasonography: a comparison between ultrasonographic morphologic imaging and histopathologic diagnosis. Am J Obstet Gynecol 184:48–54CrossRefPubMedGoogle Scholar
  23. 23.
    Greenlee RT, Kessel B, Williams CR, et al. (2010) Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial. Am J Obstet Gynecol 202(373):e371–e379Google Scholar
  24. 24.
    Levine D, Gosink BB, Wolf SI, Feldesman MR, Pretorius DH (1992) Simple adnexal cysts: the natural history in postmenopausal women. Radiology 184:653–659CrossRefPubMedGoogle Scholar
  25. 25.
    Modesitt SC, Pavlik EJ, Ueland FR, et al. (2003) Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obst Gynecol 102:594–599Google Scholar
  26. 26.
    Timor-Tritsch IE, Goldstein SR (2005) The complexity of a “complex mass” and the simplicity of a “simple cyst”. J Ultrasound Med 24:255–258CrossRefPubMedGoogle Scholar
  27. 27.
    Valentin L, Ameye L, Franchi D, et al. (2013) Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature. Ultrasound Obstet Gynecol 41:80–89CrossRefPubMedGoogle Scholar
  28. 28.
    Thomassin-Naggara I, Aubert E, Rockall A, et al. (2013) Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 267:432–443CrossRefPubMedGoogle Scholar
  29. 29.
    Hricak H, Chen M, Coakley FV, et al. (2000) Complex adnexal masses: detection and characterization with MR imaging–multivariate analysis. Radiology 214:39–46CrossRefPubMedGoogle Scholar
  30. 30.
    Sohaib SA, Mills TD, Sahdev A, et al. (2005) The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol 60:340–348CrossRefPubMedGoogle Scholar
  31. 31.
    Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH (2003) Characterization of adnexal mass lesions on MR imaging. Am J Roentgenol 180:1297–1304CrossRefGoogle Scholar
  32. 32.
  33. 33.
  34. 34.
    Kurman RJ, Shih IM (2016) The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol 186:733–747CrossRefPubMedGoogle Scholar
  35. 35.
    Lim D, Oliva E (2013) Precursors and pathogenesis of ovarian carcinoma. Pathology 45:229–242CrossRefPubMedGoogle Scholar
  36. 36.
    Salvador S, Gilks B, Kobel M, et al. (2009) The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer 19:58–64CrossRefPubMedGoogle Scholar
  37. 37.
    Munksgaard PS, Blaakaer J (2011) The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol 123:157–163CrossRefPubMedGoogle Scholar
  38. 38.
    Berns EM, Bowtell DD (2012) The changing view of high-grade serous ovarian cancer. Cancer Res 72:2701–2704CrossRefPubMedGoogle Scholar
  39. 39.
    Meinhold-Heerlein I, Fotopoulou C, Harter P, et al. (2016) The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet 293:695–700CrossRefPubMedGoogle Scholar
  40. 40.
    Kaijser J, Vandecaveye V, Deroose CM, et al. (2014) Imaging techniques for the pre-surgical diagnosis of adnexal tumours. Best Pract Res Clin Obstet Gynaecol 28:683–695CrossRefPubMedGoogle Scholar
  41. 41.
    Shim SH, Kim SN, Jung PS, et al. (2016) Impact of surgical staging on prognosis in patients with borderline ovarian tumours: a meta-analysis. Eur J Cancer 54:84–95CrossRefPubMedGoogle Scholar
  42. 42.
    Anthoulakis C, Nikoloudis N (2014) Pelvic MRI as the “gold standard” in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review. Gynecol Oncol 132:661–668CrossRefPubMedGoogle Scholar
  43. 43.
    Van Calster B, Van Hoorde K, Valentin L, et al. (2014) Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 349:g5920CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Brun JL, Fritel X, Aubard Y, et al. (2014) Management of presumed benign ovarian tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol 183:52–58CrossRefPubMedGoogle Scholar
  45. 45.
    Guerriero S, Alcazar JL, Coccia ME, et al. (2002) Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: results of a multicenter European study. J Ultrasound Med 21:1105–1111CrossRefPubMedGoogle Scholar
  46. 46.
    Valentin L (1999) Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol 14:273–283CrossRefPubMedGoogle Scholar
  47. 47.
    Stein SM, Laifer-Narin S, Johnson MB, et al. (1995) Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. Am J Roentgenol 164:381–386CrossRefGoogle Scholar
  48. 48.
    Buy JN, Ghossain MA, Hugol D, et al. (1996) Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. Am J Roentgenol 166:385–393CrossRefGoogle Scholar
  49. 49.
    Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC (2009) Accuracy of ultrasonography with color Doppler in ovarian tumor: a systematic quantitative review. Int J Gynecol Cancer 19:1214–1220CrossRefPubMedGoogle Scholar
  50. 50.
    Sokalska A, Timmerman D, Testa AC, et al. (2009) Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol 34:462–470CrossRefPubMedGoogle Scholar
  51. 51.
    Levine D, Brown DL, Andreotti RF, et al. (2010) Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 26:121–131CrossRefPubMedGoogle Scholar
  52. 52.
    Siegelman ES, Outwater EK (1999) Tissue characterization in the female pelvis by means of MR imaging. Radiology 212:5–18CrossRefPubMedGoogle Scholar
  53. 53.
    Adusumilli S, Hussain HK, Caoili EM, et al. (2006) MRI of sonographically indeterminate adnexal masses. Am J Roentgenol 187:732–740CrossRefGoogle Scholar
  54. 54.
    Tsili AC, Tsampoulas C, Argyropoulou M, et al. (2008) Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses. Eur Radiol 18:1049–1057CrossRefPubMedGoogle Scholar
  55. 55.
    Takeuchi M, Matsuzaki K, Nishitani H (2010) Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr 34:173–176CrossRefPubMedGoogle Scholar
  56. 56.
    Thomassin-Naggara I, Balvay D, Aubert E, et al. (2012) Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol 22:738–745CrossRefPubMedGoogle Scholar
  57. 57.
    Thomassin-Naggara I, Bazot M, Darai E, et al. (2008) Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology 248:148–159CrossRefPubMedGoogle Scholar
  58. 58.
    Thomassin-Naggara I, Toussaint I, Perrot N, et al. (2011) Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology 258:793–803CrossRefPubMedGoogle Scholar
  59. 59.
    Spencer JA, Forstner R, Cunha TM, Kinkel K (2010) ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach. Eur Radiol 20:25–35CrossRefPubMedGoogle Scholar
  60. 60.
    Timmerman D, Valentin L, Bourne TH, et al. (2000) Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 16:500–505CrossRefPubMedGoogle Scholar
  61. 61.
    Lalwani N, Prasad SR, Vikram R, et al. (2011) Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics 31:625–646CrossRefPubMedGoogle Scholar
  62. 62.
    Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP (2014) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology 271:126–132CrossRefPubMedGoogle Scholar
  63. 63.
    Bal A, Mohan H, Singh SB, Sehgal A (2007) Malignant transformation in mature cystic teratoma of the ovary: report of five cases and review of the literature. Arch Gynecol Obstet 275:179–182CrossRefPubMedGoogle Scholar
  64. 64.
    Khashper A, Addley HC, Abourokbah N, et al. (2012) T2-hypointense adnexal lesions: an imaging algorithm. Radiographics 32:1047–1064CrossRefPubMedGoogle Scholar
  65. 65.
    Montoriol PF, Mons A, Da Ines D, et al. (2013) Fibrous tumours of the ovary: aetiologies and MRI features. Clin Radiol 68:1276–1283CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Elizabeth A. Sadowski
    • 1
    • 2
  • Jessica B. Robbins
    • 1
  • Andrea G. Rockall
    • 3
    • 4
  • Isabelle Thomassin-Naggara
    • 5
  1. 1.Department of Radiology, Clinical Science Center, E3/372University of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Obstetrics and Gynecology, Clinical Science Center, E3/372University of Wisconsin School of Medicine and Public HealthMadisonUSA
  3. 3.Department of RadiologyThe Royal Marsden NHS Foundation TrustLondonUK
  4. 4.Divison of Surgery and CancerImperial College LondonLondonUK
  5. 5.Department of RadiologySorbonne Universités, UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Assistance Publique – Hôpitaux de Paris, Hôpital Tenon, Service d’ImagerieParisFrance

Personalised recommendations